Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Detection in professional sport can lead to suspension (WADA, 2023 Prohibited List)
This distinction is not just about qualityit's about your safety
NF-kappaB Pathway Inhibition Targeted Anti-Inflammatory Control KPV provides potent anti-inflammatory effects through direct inhibition of nuclear factor-kappa B (NF-kappaB), distinguishing KLOW from GLOW through enhanced inflammation control[3]: Competitive blocking of importin-alpha3 interaction with NF-kappaB p65/RelA subunit Prevention of NF-kappaB nuclear translocation in activated cells Inhibition of pro-inflammatory gene transcription Reduction of cytokine production including TNF-alpha, IL-1beta, and IL-6 PepT1-mediated cellular uptake enabling intracellular anti-inflammatory action This mechanism operates at nanomolar concentrations and works through a melanocortin receptor-independent pathway, providing inflammation control without hormonal side effects while complementing the other components regenerative actions
BPC-157: More localized, especially in the GI tract and connective tissue TB-500: Broader systemic effects, influencing cell migration and circulation In some cases, both may be considered together (bpc157 and tb500) as complementary, though decisions must be individualized and physician-guided
CMAJ 166 , 13071308 (2002)
US$ 26.82
US$ 24.85
US$ 23.71
US$ 27.00
